| Next 10 |
Ad
AKTS News and Press Akoustis Technologies Inc.
News | Akoustis Technologies Inc. (NASDAQ:AKTS)
-
Meta Materials Inc. (MMATQ) is expected to report for quarter end 2024-12-31 ABAXX Technologies Inc. (ABXXF) is expected to report for quarter end 2024-12-31 ClearOne Inc. (CLRO) is expected to report for quarter end 2024-12-31 SSP Group Plc (SSPPF) is expected to report for quarter e...
-
Cadeler A/S American Depositary Share (each representing four (4) Ordinary Shares) (CDLR) is expected to report $0.34 for Q4 2024 China Mengniu Dairy Company Limited ADR (CIADY) is expected to report for Q4 2024 Atossa Therapeutics Inc. (ATOS) is expected to report $-0.06 for Q4 2024 ...
-
Gritstone bio Inc. (GRTS) is expected to report for Q4 2024 OneConnect Financial Technology Co. Ltd. American Depositary Shares each representing thirty (OCFT) is expected to report for quarter end 2024-12-31 2seventy bio Inc. (TSVT) is expected to report $-0.2 for Q4 2024 CorMedix In...
-
Algoma Steel Group Inc. (ASTL) is expected to report $0.06 for Q3 2025 E.W. Scripps Company (The) (SSP) is expected to report for Q4 2024 TransAct Technologies Incorporated (TACT) is expected to report $-0.1 for Q4 2024 Kindly MD, Inc. (KDLY) is expected to report for Q4 2024 Talo...
-
Veritec, Inc. (VRTC) is expected to report for quarter end 2024-12-31 Nayax Ltd. (NYAX) is expected to report $0.04 for Q4 2024 CrowdStrike Holdings Inc. (CRWD) is expected to report $0.01 for Q4 2025 Schaeffler AG Bearer Preference Shares (SCFLF) is expected to report for quarter end...
-
ASM International NV New York Shares (ASMIY) is expected to report $3.98 for Q4 2024 Sezzle Inc. (SEZL) is expected to report $3.12 for Q4 2024 Fresenius SE & Co. KGaA ADR (FSNUY) is expected to report for Q4 2024 OraSure Technologies Inc. (OSUR) is expected to report $-0.06 for Q...
-
2024-12-16 02:30:55 ET More on Akoustis Technologies Seeking Alpha’s Quant Rating on Akoustis Technologies Historical earnings data for Akoustis Technologies Financial information for Akoustis Technologies Read the full article on Seeking Alpha ...
-
Committed to Full Continuity in Delivering Next-Generation BAW High-Band RF Filters to Customers Around the World Filing to Ensure Business Sold Free and Clear of Qorvo Infringement Following Final Judgement and Required Cleansing Process Akoustis Technologies, Inc. (NASDAQ: A...
-
CISO Global, Inc (CISO) is expected to report for Q3 2024 Applied Energetics Inc (AERG) is expected to report for Q3 2024 Sphere 3D Corp. (ANY) is expected to report $-0.19 for Q3 2024 Atossa Therapeutics Inc. (ATOS) is expected to report $-0.05 for Q3 2024 Community Bancorp Inc V...
-
2024-11-10 08:01:00 ET As the calendar approaches the middle of November, a lineup of major companies across various sectors is set to report their quarterly financial results, providing insights into the broader economic landscape and potential market trends. This week, investors will ...
Stock Information
Get AKTS Alerts
News, Short Squeeze, Breakout and More Instantly...
Akoustis Technologies Inc. Company Name:
AKTS Stock Symbol:
NASDAQ Market:
-7.53% G/L:
$0.0372 Last:
118,703,483 Volume:
$0.04 Open:
$0.0372 Close:
Akoustis Technologies Inc. Website:
Ad
-
Meta Materials Inc. (MMATQ) is expected to report for quarter end 2024-12-31 ABAXX Technologies Inc. (ABXXF) is expected to report for quarter end 2024-12-31 ClearOne Inc. (CLRO) is expected to report for quarter end 2024-12-31 SSP Group Plc (SSPPF) is expected to report for quarter e...
-
Cadeler A/S American Depositary Share (each representing four (4) Ordinary Shares) (CDLR) is expected to report $0.34 for Q4 2024 China Mengniu Dairy Company Limited ADR (CIADY) is expected to report for Q4 2024 Atossa Therapeutics Inc. (ATOS) is expected to report $-0.06 for Q4 2024 ...
-
Gritstone bio Inc. (GRTS) is expected to report for Q4 2024 OneConnect Financial Technology Co. Ltd. American Depositary Shares each representing thirty (OCFT) is expected to report for quarter end 2024-12-31 2seventy bio Inc. (TSVT) is expected to report $-0.2 for Q4 2024 CorMedix In...